维普中文期刊产品整合服务
222篇 您的检索式:作者名="EUN C"
    题名 作者 年代 出处 被引量
1High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis显示文摘AIM:To study the cost-effectiveness of high-resolution microendoscopy(HRME)in an esophageal squamous cell carcinoma(ESCC)screening program in China.METHODS:A decision analytic Markov model of ESCC was developed.Separate model analyses were conducted for cohorts consisting of an averagerisk population or a high-risk population in China.Hypothetical 50-year-old individuals were followed until age 80 or death.We compared three different strategies for both cohorts:(1)no screening;(2)standard endoscopic screening with Lugol’s iodine staining;and(3)endoscopic screening with Lugol’s iodine staining and an HRME.Model parameters were estimated from the literature as well as from GLOBOCAN,the Cancer Incidence and Mortality Worldwide cancer database.Health states in the model included non-neoplasia,mild dysplasia,moderate dysplasia,high-grade dysplasia,intramucosal carcinoma,operable cancer,inoperable cancer,and death.Separate ESCC incidence transition rates were generated for the average-risk and high-risk populations.Costs in Chinese currency were converted to international dollars(I$)and were adjusted to 2012dollars using the Consumer Price Index.RESULTS:The main outcome measurements for this study were quality-adjusted life years(QALYs)and incremental cost-effectiveness ratio(ICER).For the average-risk population,the HRME screening strategy produced 0.043 more QALYs than the no screening strategy at an additional cost of I$646,resulting in an ICER of I$11808 per QALY gained.Standard endoscopic screening was weakly dominated.Among the high-risk population,when the HRME screening strategy was compared with the standard screening strategy,the ICER was I$8173 per QALY.For both the high-risk and average-risk screening populations,the HRME screening strategy appeared to be the most cost-effective strategy,producing ICERs below the willingness-topay threshold,I$23500 per QALY.One-way sensitivity analysis showed that,for the average-risk population,higher specificity of Lugol’s iodine(>40%)and lower specificity of HRME(<70%)could make Lugol’s iodine screening cost-effective.For the high-risk population,the results of the model were not substantially affected by varying the follow-up rate after Lugol’s iodine screening,Lugol’s iodine test characteristics(sensitivity and specificity),or HRME specificity.CONCLUSION:The incorporation of HRME into an ESCC screening program could be cost-effective in China.Larger studies of HRME performance are needed to confirm these findings.Chin Hur Sung Eun Choi Chung Yin Kong Gui-Qi Wang Hong Xu Alexandros D Polydorides Li-Yan Xue Katherine E Perzan Angela C Tramontano Rebecca R Richards-Kortum Sharmila Anandasabapathy 2015World Journal of Gastroenterology2015,21,18:8
2Comparative effectiveness of adipose-derived mesenchymal stromal cells in the management of knee osteoarthritis:A meta-analysis显示文摘BACKGROUND Osteoarthritis(OA)is the most common joint disorder,is associated with an increasing socioeconomic impact owing to the ageing population.AIM To analyze and compare the efficacy and safety of bone-marrow-derived mesenchymal stromal cells(BM-MSCs)and adipose tissue-derived MSCs(AD-MSCs)in knee OA management from published randomized controlled trials(RCTs).METHODS Independent and duplicate electronic database searches were performed,including PubMed,EMBASE,Web of Science,and Cochrane Library,until August 2021 for RCTs that analyzed the efficacy and safety of AD-MSCs and BM-MSCs in the management of knee OA.The visual analog scale(VAS)score for pain,Western Ontario McMaster Universities Osteoarthritis Index(WOMAC),Lysholm score,Tegner score,magnetic resonance observation of cartilage repair tissue score,knee osteoarthritis outcome score(KOOS),and adverse events were analyzed.Analysis was performed on the R-platform using OpenMeta(Analyst)software.Twenty-one studies,involving 936 patients,were included.Only one study compared the two MSC sources without patient randomization;hence,the results of all included studies from both sources were pooled,and a comparative critical analysis was performed.RESULTS At six months,both AD-MSCs and BM-MSCs showed significant VAS improvement(P=0.015,P=0.012);this was inconsistent at 1 year for BM-MSCs(P<0.001,P=0.539),and AD-MSCs outperformed BM-MSCs compared to controls in measures such as WOMAC(P<0.001,P=0.541),Lysholm scores(P=0.006;P=0.933),and KOOS(P=0.002;P=0.012).BM-MSC-related procedures caused significant adverse events(P=0.003)compared to AD-MSCs(P=0.673).CONCLUSION Adipose tissue is superior to bone marrow because of its safety and consistent efficacy in improving pain and functional outcomes.Future trials are urgently warranted to validate our findings and reach a consensus on the ideal source of MSCs for managing knee OA.Sathish Muthu Sandesh C Patil Naveen Jeyaraman Madhan Jeyaraman Prakash Gangadaran Ramya Lakshmi Rajendran Eun Jung Oh Manish Khanna Ho Yun Chung Byeong-Cheol Ahn 2023World Journal of Orthopedics2023,14,1:2
3Extrapedieular approach of percutaneous vertebroplasty in the treatment of upper and mid-thoracic vertebral compression fracture显示文摘Han KR Kim C Eun JS 2005Acta Radio12005,46,3:1
4International Transmission of Stock Market Movements显示文摘Eun C S Shim S 1989Journal of Financial And Quantitative Analysis1989,24,2:1
5Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-me- diated apoptosis through CHOP-independent DR5 upregulation 显示文摘Eun M J Park J W Kyeong S C 2006Carcinogenesis2006,27,10:1
6Conjugated linoeic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line显示文摘HAN J C WOO K K EUN J K 2003Am J Phsiol Gstrointest Liver Phsiol2003,284,:1
7Extrapedicular approach of percutaneous vertebroplasty in the treatment of upper and mid - thoracic vertebral compression fracture显示文摘Han KR Kim C Eun JS 2005Acta Radiol2005,3,:1
8Extrapedicular approach of percutaneous vertebroplasty in the treatment of upper and mid-thoracic vertebral compression fracture显示文摘 Kim C Eun JS 2005Acta Radiol2005,46,3:1
9Recent progress in passive direct methanol fuel cells at KIST显示文摘Daejin K Eun A C Song A H 2004Journal of Power Sources2004,13,12:1
10Water-soluble ultra small paramagnetic or superparamagnetic metal oxide nanoparticles for molecular MR imaging显示文摘JA Y P EUN S C MYUNG J B 2009Eur J Inorg Chem2009,17,:1
11Production of lactic acid by Lactobacillus rhamnosus with vitamin-supplemented soybean hydrolysate显示文摘SUNHOON K PYUNG C L EUN G L 2000Enzyme and Microbial Technology2000,26,:1
12A new volterra predistorter based on the indirect learning architecture显示文摘Eun C Powers E J 1997IEEE Transactions on Signal Processing1997,45,1:1
13A new Volterra predistorter based on the indirect learning architecture 显示文摘Eun C Powers E J 1997IEEE Transactions on Signal Processing1997,45,1:1
14Supplementation of standardized lipid-soluble extract from maca (Lepidium meyenii) increases swimming endurance capacity in rats显示文摘Eun H C Jung II K Jae Y C 2012Journal of Functional Foods2012,4,2:1
15Robust controller design for uncertain systems with time delays: LMI approach显示文摘EUN T J DO C O JONG H K 1996Automatic1996,32,8:1
16Distally based anterolateral-thigh(ALT)flap with the aid of multidetector computed tomography显示文摘Heo C Eun S Bae R 0,,:1
17Hesperetin induced Gl-phase cell cycle arrest in human breast cancer MCF-? ceils: involvement of CDK4 and p21 显示文摘Eun J C 2007nutr cancer2007,59,1:1
18Identification of tumor suppressor loci on the long arm of chromosome 4 in primary small cell lung cancers显示文摘Eun SC Joon C Kyung YC 2002Yonsei Medical Journal2002,2,43:1
19Methylene chloride fraction of ScuteUaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway显示文摘Yun Y C Eun O L Hyo J L 2004Clinica Chimica Acta2004,348,12:1
20Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains 显示文摘Byoung K Seung O Eun C Seung P 2006Tuberc Respir Dis2006,60,2:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费